A REVIEW ON LIPOMA AND ITS GENETIC INTERVENTIONS

  • Jisa Elizabath Sabu Department of Pharmacology, Nirmala college of Pharmacy, Muvattupuzha, Ernakulam, Kerala-686661
  • Bharat Mishra Nirmala College of Pharmacy, Muvattupuzha, Ernakulam, Kerala.
  • Angelin Jaimon Augustine Department of Pharmacology, Nirmala college of Pharmacy, Muvattupuzha, Ernakulam, Kerala-686661
  • Aleesha R

Abstract

Lipomas are benign soft tissue fatty tumours that most commonly appear in the third decade of life when fatty tissue accumulates. Histologically, lipoma is composed of mature fat cells with a thin fibrous capsule. Simple lipomas account for 80% of adipose tissue tumours. The aetiology may be genetic like Familial Multiple Lipomatosis. Some tumours, like the well differentiated Liposarcomas never metastasize unless they undergo de-differentiation. They can be introduced as Atypical Lipomatous Tissue, ALT. Southern blot analysis is performed by obtaining DNA from ALT, cases in which most of them are characterized by the presence of supernumerary ring and long marker chromosomes. The complex chromosome region contains genes MDM2, CDK4, HMGI- C, SAS, GLI, CHOP, OS4 and OSP. Most of ALTs, after analysis revealed amplification of CDK4 and MDM2 proto- oncogenes that play major role in permitting over ride of block operated on cell proliferation.  Immuno-histochemical results have shown MDM2 over expression in about 50% of ALTs along with weak CDK4 immuno-positivity. Also the lipomas with Gene fusion transcripts have the expression of certain genes, HMGA2/LPP, HMGA2/RDCI and HMGA2/NFIB. Of these 98% of cases were analyzed for the possible expression of HMGA2/LPP and LPP- HMGA2 fusion genes using reverse transcription polymerase chain reaction. Over all these cases, shows non-enhanced adipocyte apoptosis and enhanced adipogenesis in lipoma tissue. Thus studies provide insights into molecular pathogenesis of lipomatous tumour and representation of distinctive subset of mesenchymal neoplasms with mature adipocyte differentiation.

Keywords: Lipoma, Liposarcomas, Lipomatosis, Adipogenesis, Mesenchymal Neoplasms

Downloads

Download data is not yet available.

References

1. Kim KS, Yang HS. Unusual locations of lipoma: differential diagnosis of head and neck mass. Australian family physician. 2014 Dec;43(12):867.
2. Han HH, Choi JY, Seo BF, Moon SH, Oh DY, Ahn ST, Rhie JW. Treatment for intramuscular lipoma frequently confused with sarcoma: a 6-year restrospective study and literature review. BioMed research international. 2014 Jan 1;2014.
3. Kooby DA, Antonescu CR, Brennan MF, Singer S. Atypical lipomatous tumor/well-differentiated liposarcoma of the extremity and trunk wall: importance of histological subtype with treatment recommendations. Annals of surgical oncology. 2004 Jan 1;11(1):78-84.
4. https://emedicine.medscape.com/article/191233-overview - March 2020
5. Allen B, Rader C, Babigian A. Giant lipomas of the upper extremity. Canadian Journal of Plastic Surgery. 2007 Sep;15(3):141-4.
6. Panagopoulos I, GORUNOvA LU, BJERkEHAGEN BO, Lobmaier I, Heim S. The recurrent chromosomal translocation t (12; 18)(q14~ 15; q12~ 21) causes the fusion gene HMGA2-SETBP1 and HMGA2 expression in lipoma and osteochondrolipoma. International journal of oncology. 2015 Sep 1;47(3):884-90.
7. Bell T. What is liposarcoma?.
8. Nassif NA, Tseng W, Borges C, Chen P, Eisenberg B. Recent advances in the management of liposarcoma. F1000Research. 2016;5.
9. Rauh J, Klein A, Baur-Melnyk A, Knösel T, Lindner L, Roeder F, Jansson V, Dürr HR. The role of surgical margins in atypical Lipomatous Tumours of the extremities. BMC Musculoskeletal Disorders. 2018 Dec;19(1):1-7.
10. Awh MH. MRI Web Clinic—January 2014.
11. Dei Tos AP, Doglioni C, Piccinin S, Sciot R, Furlanetto A, Boiocchi M, Dal Cin P, Maestro R, Fletcher CD, Tallini G. Coordinated expression and amplification of the MDM2, CDK4, and HMGI‐C genes in atypical lipomatous tumours. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland. 2000 Apr;190(5):531-6.
12. He M, Aisner S, Benevenia J, Patterson F, Aviv H, Hameed M. p16 immunohistochemistry as an alternative marker to distinguish atypical lipomatous tumor from deep-seated lipoma. Applied Immunohistochemistry & Molecular Morphology. 2009 Jan 1;17(1):51-6.
13. Hatano H, Morita T, Ogose A, Hotta T, Kobayashi H, Segawa H, Uchiyama T, TAKENOUCHI T, Sato T. Clinicopathological features of lipomas with gene fusions involving HMGA2. Anticancer research. 2008 Jan 1;28(1B):535-8.
14. Nilsson M, Panagopoulos I, Mertens F, Mandahl N. Fusion of the HMGA2 and NFIB genes in lipoma. Virchows Archiv. 2005 Nov 1;447(5):855-8.
15. Binh MB, Sastre-Garau X, Guillou L, de Pinieux G, Terrier P, Lagacé R, Aurias A, Hostein I, Coindre JM. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data. The American journal of surgical pathology. 2005 Oct 1;29(10):1340-7.
16. Juven T, Barak Y, Zauberman A, George DL, Oren M. Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogene. 1993 Dec 1;8(12):3411-6.
17. Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ, Look AT. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer research. 1993 Nov 15;53(22):5535-41.
18. Gattas GJ, Quade BJ, Nowak RA, Morton CC. HMGIC expression in human adult and fetal tissues and in uterine leiomyomata. Genes, Chromosomes and Cancer. 1999 Aug;25(4):316-22.
19. Su YA, Hutter CM, Trent JM, Meltzer PS. Complete sequence analysis of a gene (OS‐9) ubiquitously expressed in human tissues and amplified in sarcomas. Molecular Carcinogenesis: Published in cooperation with the University of Texas MD Anderson Cancer Center. 1996 Apr;15(4):270-5.
20. Jankowski SA, Mitchell DS, Smith SH, Trent JM, Meltzer PS. SAS, a gene amplified in human sarcomas, encodes a new member of the transmembrane 4 superfamily of proteins. Oncogene. 1994 Apr 1;9(4):1205-11.
21. Rahnama F, Shimokawa T, Lauth M, Finta C, Kogerman P, Teglund S, Toftgård R, Zaphiropoulos PG. Inhibition of GLI1 gene activation by Patched1. Biochemical Journal. 2006 Feb 15;394(1):19-26.
22. Hu H, Tian M, Ding C, Yu S. The C/EBP homologous protein (CHOP) transcription factor functions in endoplasmic reticulum stress-induced apoptosis and microbial infection. Frontiers in immunology. 2019 Jan 4;9:3083.
23. Kubo T, Matsui Y, Naka N, Araki N, Goto T, Yukata K, Endo K, Yasui N, Myoui A, Kawabata H, Yoshikawa H. Expression of HMGA2-LPP and LPP-HMGA2 fusion genes in lipoma: identification of a novel type of LPP-HMGA2 transcript in four cases. Anticancer research. 2009 Jun 1;29(6):2357-60.
24. Arrigoni G, Doglioni C. Atypical lipomatous tumor: molecular characterization. Current opinion in oncology. 2004 Jul 1;16(4):355-8.
25. Boltze C, Schneider-Stock R, Jäger V, Roessner A. Distinction between lipoma and liposarcoma by MDM2 alterations: a case report of simultaneously occurring tumors and review of the literature. Pathology-Research and Practice. 2001 Jan 1;197(8):563-8.
26. Perez M, Muñoz-Galván S, Jiménez-García MP, Marín JJ, Carnero A. Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA. Oncotarget. 2015 Dec 1;6(38):40557.
27. Fedele M, Battista S, Manfioletti G, Croce CM, Giancotti V, Fusco A. Role of the high mobility group A proteins in human lipomas. Carcinogenesis. 2001 Oct 1;22(10):1583-91.
28. Milgram JW. Malignant transformation in bone lipomas. Skeletal radiology. 1990 Jul 1;19(5):347-52.
29. Tallini G, Dal Cin P, Rhoden KJ, Chiapetta G, Manfioletti G, Giancotti V, Fusco A, Van den Berghe H, Sciot R. Expression of HMGI-C and HMGI (Y) in ordinary lipoma and atypical lipomatous tumors: immunohistochemical reactivity correlates with karyotypic alterations. The American journal of pathology.
30. McTighe S, Chernev I. Intramuscular lipoma: a review of the literature. Orthopedic reviews. 2014 Oct 27;6(4).
31. Burt AM, Huang BK. Imaging review of lipomatous musculoskeletal lesions. Sicot-j. 2017;3.
Published
09/11/2020
Statistics
789 Views | 818 Downloads
Citatons
How to Cite
[1]
Jisa Elizabath Sabu, Bharat Mishra, Angelin Jaimon Augustine, and Aleesha R, “A REVIEW ON LIPOMA AND ITS GENETIC INTERVENTIONS”, Int J Indig Herb Drug, pp. 6-10, Nov. 2020.
Section
Review Articles